Researchers at The Wistar Institute have discovered that ovarian cancer cells surviving chemotherapy can release fructose, which acts as a signal encouraging nearby tumor cells to break free and spread. The findings, published in Nature Aging, also suggest that commonly prescribed cholesterol-lowering statins may produce a similar effect, potentially raising new questions about the interaction between diet, medication, and cancer treatment.
The study’s first author was postdoctoral fellow Aidan Cole, and its senior author was Katherine Aird. The researchers examined how cancer cells surviving chemotherapy may influence cancer spread. Although many patients initially respond well, the cancer eventually recurs in most cases and frequently spreads throughout the abdominal cavity, a process responsible for roughly 90% of ovarian cancer deaths.
Previous research had suggested that cancer cells surviving chemotherapy might contribute to recurrence even when no longer actively dividing. The Wistar team developed an experiment to separate surviving cells from the molecules they released. They found that these released substances, even without the surviving cells themselves, were enough to significantly increase cancer spread in a preclinical model.
“As far as we know, this is the first time anyone has shown, in a preclinical model rather than just a dish, that it’s the molecules these cells release — not the cells themselves — that drive the cancer’s spread,” Cole said.
To identify which substances encouraged cancer cells to spread, the researchers discovered an unexpected culprit: fructose, a natural sugar found in fruit, honey, and a component of table sugar and high fructose corn syrup. The team found that cancer cells surviving chemotherapy could produce fructose and release it into their surroundings, where it acted as a chemical messenger rather than an energy source. That signal encouraged neighboring cancer cells to become more capable of spreading.
Using a CRISPR screen and other advanced techniques, the researchers traced how fructose promotes this spread. The sugar was found to suppress cholesterol production in neighboring cancer cells. Since cholesterol helps maintain the connections that hold cells together, reducing it weakens those bonds, allowing cells to detach more easily.
“Some cancer cells that survive chemotherapy aren’t dividing anymore, but they’re still biologically active,” Cole said. “Instead, they continue to release molecules that send signals to nearby cells. Our study is among the first to show that a nutrient — in this case, fructose — can act as one of those signals.”
In additional experiments, the team found that statins, drugs taken by about 39 million people in the United States to lower cholesterol, could also weaken the connections between cancer cells, mimicking the effect of fructose. “We haven’t tested this effect in patients yet, but it raises questions about combining cholesterol-lowering drugs with chemotherapy, especially since ovarian cancer is most common in postmenopausal women who are often already on statins,” Aird said.
The researchers cautioned that the findings have not been demonstrated in patients and are not a reason for anyone to discontinue prescribed statins. High fructose corn syrup can account for approximately 8% to 20% of daily calorie intake in some individuals, and the findings suggest diet might influence cancer progression. Researchers have not yet tested whether reducing fructose improves patient outcomes.
Aird said the same biological process could occur in other cancers that spread within the torso, such as pancreatic, colon, and liver cancers. Aird and Cole have begun designing experiments to investigate those possibilities.
Analysis
Why This Matters
- The discovery identifies a novel mechanism by which cancer cells can influence spread even after being stopped by chemotherapy, potentially opening a new avenue for preventing metastasis.
- Fructose is a modifiable dietary factor, raising the possibility of nutritional strategies to limit cancer spread, though human studies are needed.
- The link to statins could affect how cancer patients’ medications are managed, particularly in postmenopausal women who may already be taking cholesterol-lowering drugs.
Background
Ovarian cancer is the fifth leading cause of cancer death among women. About 90% of ovarian cancer deaths result from metastasis, the spread of cancer cells to other parts of the body. Platinum-based chemotherapy is the standard treatment, and while it often initially works, most patients eventually relapse. Scientists have long sought to understand how surviving cancer cells contribute to recurrence. This study is among the first to identify a specific nutrient, fructose, as a signaling molecule in that process.
Key Perspectives
- Aidan Cole, Ph.D., first author (Wistar Institute): “Some cancer cells that survive chemotherapy aren’t dividing anymore, but they’re still biologically active … Our study is among the first to show that a nutrient — in this case, fructose — can act as one of those signals.”
- Katherine Aird, Ph.D., senior author (Wistar Institute): “We haven’t tested this effect in patients yet, but it raises questions about combining cholesterol-lowering drugs with chemotherapy …” She also noted the potential for the mechanism to apply to other cancers: “We think other cancers that spread within the torso — pancreatic, colon, liver — could behave similarly.”
What to Watch
- Human studies examining whether reducing dietary fructose intake improves outcomes for ovarian cancer patients.
- Clinical data on whether statin use during chemotherapy is associated with altered rates of metastasis.
- Expansion of similar experiments to pancreatic, colon, and liver cancers to test the generality of the fructose–cholesterol–cell connection mechanism.
Checked
12 claims in this story checked against 1 source: 11 supported.
Show each claim
- SupportedFructose may help ovarian cancer cells break free and spread.Latest Science News -- ScienceDaily: “Researchers at The Wistar Institute have discovered that cancer cells surviving chemotherapy can release fructose, which acts as a signal that encourages nearby tumor cells to break free and spread.”
- SupportedStatins might play a similar role to fructose in weakening cancer-cell connections.Latest Science News -- ScienceDaily: “Their experiments showed that statins alone could weaken the connections between cancer cells, making it easier for them to separate and escape.”
- Partly supportedThe summary links diet and chemotherapy interactions as questions raised by the findings.Latest Science News -- ScienceDaily: “The finding raises questions about whether cholesterol-lowering medications could influence the effectiveness of chemotherapy in certain situations.”
- SupportedCole said the study showed, in a preclinical model, that molecules released by surviving cells—not the cells themselves—drive cancer spread.Latest Science News -- ScienceDaily: “"As far as we know, this is the first time anyone has shown, in a preclinical model rather than just a dish, that it's the molecules these cells release -- not the cells themselves -- that drive the cancer's spread," said Cole.”
- SupportedThe released molecules, without the surviving cells, significantly increased cancer spread in a preclinical model.Latest Science News -- ScienceDaily: “They discovered that these released substances, even without the surviving cells themselves, were enough to significantly increase cancer spread in a preclinical model.”
- SupportedFructose released by surviving cancer cells acted as a chemical messenger that made neighboring cancer cells more capable of spreading.Latest Science News -- ScienceDaily: “Rather than simply serving as an energy source, the sugar acted as a chemical messenger that encouraged neighboring cancer cells to become more capable of spreading.”
- SupportedFructose suppresses cholesterol production in nearby cancer cells, weakening connections that help hold cells together.Latest Science News -- ScienceDaily: “The experiments revealed that fructose suppresses cholesterol production in neighboring cancer cells. [...] When fructose reduces cholesterol production, those connections weaken.”
- SupportedCole said the study was among the first to show that a nutrient such as fructose can signal nearby cells.Latest Science News -- ScienceDaily: “"Instead, they continue to release molecules that send signals to nearby cells. Our study is among the first to show that a nutrient -- in this case, fructose -- can act as one of those signals."”
- SupportedAbout 39 million people in the United States take statins to lower cholesterol.Latest Science News -- ScienceDaily: “Approximately 39 million people in the United States take statins.”
- SupportedAird said the effect has not been tested in patients and raised questions about combining cholesterol-lowering drugs with chemotherapy.Latest Science News -- ScienceDaily: “"We haven't tested this effect in patients yet, but it raises questions about combining cholesterol-lowering drugs with chemotherapy, especially since ovarian cancer is most common in postmenopausal women who are often already on statins," said Katherine Aird.”
- SupportedThe spread of ovarian cancer through the abdominal cavity is responsible for roughly 90% of ovarian cancer deaths.Latest Science News -- ScienceDaily: “This spread, known as metastasis, is responsible for approximately 90% of ovarian cancer deaths.”
- SupportedAird said the same process could occur in pancreatic, colon and liver cancers, and that she and Cole had begun designing experiments to investigate.Latest Science News -- ScienceDaily: “"We think other cancers that spread within the torso -- pancreatic, colon, liver -- could behave similarly. [...]" Aird and Cole have already begun designing additional experiments to determine whether their findings can be reproduced in pancreatic, colon, liver, and other cancers.”